ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Operating Income

Profit from core operations after operating expenses, before interest and taxes.

No reported Operating Income figures are available to summarize.

Operating Income history

Currency unavailable · from the income statement

No Operating Income data reported for this period type.

Operating Income vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Operating Income for ADRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PRQRProQR Therapeutics N.V.LTM Mar 2026-€46.45M EUR-39.8%—345.5%
BNTCBenitec Biopharma Inc.LTM Mar 2026-$53.94M USD-43.9%——
RNAAtrium Therapeutics, Inc.FY2025-$76.81M USD——412.6%
SLNSilence Therapeutics plcLTM Mar 2026-$86.59M USD——9396.6%
ARCTArcturus Therapeutics Holdings Inc.LTM Mar 2026-$89.22M USD-8.7%—196.7%
MGTXMeiraGTx Holdings plcLTM Mar 2026-$105.19M USD+33.9%—131.9%
STOKStoke Therapeutics, Inc.LTM Mar 2026-$185.25M USD-584.4%—577.5%
WVEWave Life Sciences Ltd.LTM Mar 2026-$196.88M USD-56.6%—274.2%
PRMEPrime Medicine, Inc.LTM Mar 2026-$206.61M USD-0.0%—5121.8%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-39.8%—379.0%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.